“Molecular-Docking Study of Quinazolin-4(3H)-One Derivatives Against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment”. 2020. International Journal of Pharmaceutical Sciences and Drug Research 12 (5): 572-75. https://doi.org/10.25004/IJPSDR.2020.120521.